Patents by Inventor Robert J. Distel

Robert J. Distel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240408139
    Abstract: Disclosed are receptor cytokine switches, immune cells containing them, and uses thereof for controllable adoptive cell therapy.
    Type: Application
    Filed: October 5, 2022
    Publication date: December 12, 2024
    Inventors: Carl NOVINA, Aya KOBAYASHI, Robert J. DISTEL, Alberto NOBILI, Steven NEIER
  • Publication number: 20240197884
    Abstract: The present invention provides universal immunotherapy compositions useful for targeted treatment of cancers. The present invention utilizes in its various aspects, bifunctional compounds or complexes that contain at least two domains. One domain, referred to herein as a targeting moiety, binds an antigen on the surface of a tumor cell. The other domain, referred to herein as a pro-antigen, is designed to be inert to normal (non-diseased) cells and tissues, and to become activated (or “unmasked” or “uncaged”) only upon exposure to light of an appropriate wavelength.
    Type: Application
    Filed: January 31, 2024
    Publication date: June 20, 2024
    Inventors: Carl Novina, Robert J. Distel, Steven Neier, Alberto Nobili
  • Publication number: 20210137987
    Abstract: Disclosed are compositions and methods for treating cancers characterized by the presence of solid tumors, which simultaneously target a plurality of targets on cancer cells using single CAR T construct.
    Type: Application
    Filed: June 27, 2019
    Publication date: May 13, 2021
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Carl Novina, Robert J. Distel, Alberto Nobili, Steven C. Neier
  • Publication number: 20200306376
    Abstract: The present invention provides universal immunotherapy compositions useful for targeted treatment of cancers. The present invention utilizes in its various aspects, bifunctional compounds or complexes that contain at least two domains. One domain, referred to herein as a targeting moiety, binds an antigen on the surface of a tumor cell. The other domain, referred to herein as a pro-antigen, is designed to be inert to normal (non-diseased) cells and tissues, and to become activated (or “unmasked” or “unaged”) only upon exposure to light of an appropriate wavelength.
    Type: Application
    Filed: April 25, 2018
    Publication date: October 1, 2020
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Carl Novina, Robert J. Distel, Steven Neier, Alberto Nobili
  • Patent number: 10379018
    Abstract: Systems, methods, and apparatus are disclosed for recovering one or more target cells from a fluid sample. A first chamber aligned with a first surface of a removable filter receives the fluid sample. The removable filter defines a plurality of pores configured to retain the one or more target cells on the first surface and/or in the plurality of pores, each pore of the plurality of pores having a first diameter smaller than a diameter of the one or more target cells in the first surface and a second diameter greater than the first diameter in a second surface of the removable filter. A second chamber comprises a hydrophilic microporous wick structure configured to contact the second surface of the removable filter and capillarize any non-target cells and fluid from the fluid sample, drawing them into the second chamber.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: August 13, 2019
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Robert J. Distel, Yvon E. Cayre
  • Publication number: 20170336307
    Abstract: Systems, methods, and apparatus are disclosed for recovering one or more target cells from a fluid sample. A first chamber aligned with a first surface of a removable filter receives the fluid sample. The removable filter defines a plurality of pores configured to retain the one or more target cells on the first surface and/or in the plurality of pores, each pore of the plurality of pores having a first diameter smaller than a diameter of the one or more target cells in the first surface and a second diameter greater than the first diameter in a second surface of the removable filter. A second chamber comprises a hydrophilic microporous wick structure configured to contact the second surface of the removable filter and capillarize any non-target cells and fluid from the fluid sample, drawing them into the second chamber.
    Type: Application
    Filed: July 7, 2015
    Publication date: November 23, 2017
    Inventors: Robert J. DISTEL, Yvon E. CAYRE
  • Publication number: 20150110717
    Abstract: Methods and materials for increasing the number of target cells recovered from a fluid sample containing cells are described. The methods include isolating the target cells on a filter and then implanting the filter containing the target cells in an immunodeficient non-human animal, where at least some of the target cells can proliferate.
    Type: Application
    Filed: September 7, 2012
    Publication date: April 23, 2015
    Applicants: SCREENCELL, DANA FARBER CANCER INSTITUTE, INC.
    Inventors: Robert J. Distel, Yvon Cayre